Our results showed marked upregulation of E2F1, E2F2, E2F3, E2F6, E2F7, and E2F8 in WHO III glioma (Figure 1(c-d); Supplementary Figure 1(b)). This evidence concerns the gene E2F3 and central nervous system cancer.